INTRODUCTION
Human (pro)renin receptor (hPRR) is composed of an extracellular domain, a transmembrane domain and a cytoplasmic domain. Following cloning from a human kidney cDNA library, hPRR was found to bind to both renin and prorenin (1). Suzuki et al. showed that specific protein binding with the "handle" region of the prosegment in human prorenin led to its non-proteolytic activation presumably by conformational changes, and predicted that such a region played a key role in the binding with specific proteins (2) . Recently, a large number of studies have reported that this receptor, and its mechanism of binding to renin/prorenin, involves the generation or action of angiotensin, leading to numerous cardiovascular diseases (3−5) . Consequently, the development of hPRR receptor blockers is receiving considerable attention at present.
Also, an understanding of the functional properties of hPRR through detailed biochemical and biophysical analysis is urgently required.
Many reports examining receptor functionality and structure have found the extracellular domain to play a key role in affecting the binding affinity with the receptor's ligand (6, 7). Given this, expression of the typically soluble extracellular domain of a receptor, rather than its full−length form, can be employed to study the functions of a protein. Through this approach, the use of detergents can be avoided and research on protein structure and function would be facilitated. In contrast, the transmembrane domains of some receptors have been found to be very important in the process of constitutive oligomerization (8), and in the stability (9) and functioning of the receptor (10). If this is the case, preparation of the full−length of protein will be necessary. However, to our knowledge, the direct binding affinity of full−length hPRR and its extracellular domain to ligand has not been reported until now.
In a previous study, we successfully expressed full−length hPRR in silkworm larvae, and identified its location in the microsomal fraction of the fat body (11). In this study, the full−length hPRR (hPRR), hPRR lacking cytoplasmic domain (hPRR−ΔCD), and extracellular domain of hPRR (hPRR−ΔTMΔCD) were expressed in silkworm larvae to investigate the mechanism of interaction between receptor and ligand using real−time monitored surface plasmon resonance (SPR).
MATERIALS AND METHODS
Construction of recombinant BmMNPV/hPRR, /hPRR−ΔCD, /hPRR−ΔTMΔCD, and /ΔBmgp64−hPRR−ΔΤΜΔCD bacmids The full−length human PRR gene and recombinant BmMNPV/hPRR bacmid were prepared as previously described (11). In a similar manner, the hPRR gene lacking the transmembrane and cytoplasmic domain (hPRR−ΔTMΔCD) was amplified for secretory expression by PCR with the concurrent introduction of cloning sites Pst I and EcoR I at the 5' and 3' terminus, respectively, and the introduction of a FLAG tag behind the Pst I site. The 5'primer sequence (F1) was TCACTGCAGACTACAAGGACGACGACGACAAGAACGAGTTTAGTATATTAA 21
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AATCACCAG whilst that of the 3'primer (R1) was GACGAATTCCTAATATTCAAAATT (cloning sites are underlined, the FLAG codons are fenced). The stop codon was introduced immediately following the last extracellular domain codon (Tyr311) and before the EcoRI site to prevent further translation. The amplified hPRR−ΔTMΔCD digested by Pst I and EcoR I was cloned into pBlueBacHis2/GFP uv which was also digested by Pst I and EcoR I (12). For addition of the foreign bombyxin signal sequence, the resulting construct was amplified using 5'−CACC Gateway Cloning Technology (Invitrogen). The pDEST8/hPRR−ΔTMΔCD plasmid generated was transformed into E. coli Bm DH10Bac competent cells containing the BmMNPV bacmid (13) and the white Kanamycin and Gentamicin−resistant colonies were selected. The recombinant BmMNPV/hPRR−ΔTMΔCD bacmid was isolated and its identity confirmed by PCR using the 5' primer described above and M13 reverse sequencing primer (Invitrogen).
The human PRR gene lacking the cytoplasmic domain (hPRR−ΔCD) was amplified from the pENTR/D−hPRR (11) by PCR with the 5'primer (F2) as described above and 5'−TCAGTAAGAGGTGATAATCACAGCCAAGGCCAAGGCGATC−3' as the 3'primer (R2). The PCR product was inserted into pENTR by TOPO cloning, ΔBmgp64−hPRR−ΔTMΔCD fusion gene was amplified by PCR using Bmgp64F and Bmgp64R, and inserted into a pENTR/D/TOPO vector by TOPO cloning. The procedures which followed after this process were performed using the same protocol as for the construction of the recombinant BmMNPV/hPRR−ΔTMΔCD bacmid.
Injection of recombinant BmMNPV bacmids into silkworm larvae
Fifth−instar silkworm larvae (Ehime Sansyu, Ehime, Japan) were injected with the recombinant BmMNPV bacmid DNA solutions (4 μg of bacmid DNA, 5 μl of DMRIE−C transfection reagent (Invitrogen), dissolved in PBS buffer to 45 μl per larva). Five days post−injection, the hemolymph and fat body were collected by cutting Hemolymph was pre−treated by a 10−fold dilution with Buffer A and centrifugation at 114,000 × g for 60 min to allow the complete removal of insoluble materials.
Every procedure described above was carried out at 4°C whilst the prepared samples were stored at −80°C for use in future binding assays or for purification.
Purification of hPRRs
The soluble microsomal fraction of the fat body was incubated in batches with 0.5 ml of anti−FLAG M2 antibody agarose resin (Sigma− Aldrich, St. Louis, MO, USA) for 1.5 hours at 4°C. And then the resin was loaded into a gravity column and washed with 10 ml of wash buffer (50 mM sodium phosphate, 150 mM NaCl, protease inhibitors and 0.2% DDM, pH 8.0; Buffer C). The hPRR was eluted with 4.5 ml of elution buffer (50 mM sodium phosphate, 150 mM NaCl, 0.2% DDM, 100 μg/ml of FLAG peptide and protease inhibitors, pH 8.0; Buffer D).
Purification from pre−treated hemolymph was performed by following a similar procedure using anti−FLAG M2 antibody agarose resin, but without the addition of detergent to the buffers.
The protein concentration was measured by using a BCA protein assay reagent kit (Thermo Scientific Rockford, IL, USA) and bovine serum albumin as a standard.
SDS−PAGE and Western blotting analysis SDS−PAGE was performed in
10% polyacrylamide gel in a Mini−protean II system (Bio−Rad, Hercules, CA, USA).
The GFP uv −fused protein was visualized using a Molecular−FX multi−imager 
RESULTS AND DISCUSSION
Expression and purification of three forms of hPRRs The hPRR and hPRR−ΔTMΔCD fusion proteins (Fig. 1A) collected from the hemolymph of silkworm larvae were analyzed by Western blotting using anti−FLAG−M2 antibody (Fig. 1B) .
Compared with the weak band detected for hPRR in the hemolymph, hPRR−ΔTMΔCD lacking its transmembrane and cytoplasmic domains showed a single strong band on during Western blotting, indicating that it was secreted extracellularly. Additionally, hPRR−ΔTMΔCD showed the expected molecular weight of 64 kDa. No band was The hPRR and hPRR−ΔCD fusion proteins were mostly expressed in fat body as shown in their GFP uv fluorescence analysis (Fig. 1C ), but were not detected in the hemolymph of silkworm larvae (data not shown). The size of the hPRR and hPRR−ΔCD was estimated to be 69 and 65 kDa, respectively, which was found to be principally located in the microsomal fraction of the fat body (11).
The hPRR, hPRR−ΔCD, and hPRR−ΔTMΔCD fusion proteins expressed in the fat body were purified by simple one−step anti−FLAG affinity chromatography. The results of SDS−PAGE and GFP uv fluorescence analysis of purified hPRR, hPRR−ΔCD, and hPRR−ΔTMΔCD are shown in Fig. 2A . For hPPR and hPRR−ΔCD, a major band of 69 and 65 kDa was observed. In the case of hPRR−ΔTMΔCD, SDS−PAGE showed the predicted band of 64 kDa, whereas some degraded bands below the main band were also detected by the GFP uv fluorescence analysis. This suggests that the lack of a transmembrane domain may render hPRR unstable and be readily degraded compared with the full−length version during the same purification procedure. In addition, hPRR−ΔTMΔCD could not be purified with the insect cell expression system (12) either because of this extracellular instability or because of its low expression level.
Binding assay for crude and purified hPRRs In order to compare and characterize the binding affinities of hPRR and hPRR−ΔTMΔCD, SPR experiments were carried out using an IAsys plus biosensor. Four hundred arc seconds of human renin were coupled on the cuvette of the IAsys plus biosensor. According to the method described by Li et al (14) , the amount of immobilized renin was calculated as 2.45 pmol. The prepared soluble microsomal fraction of fat body expressed hPRR and the hemolymph expressed hPRR−ΔTMΔCD were diluted to 3 mg/ml and injected into the renin immobilized cuvette. The same treatments were also performed using the microsomal fraction and hemolymph of mock−injected silkworm larvae as a control.
The results derived from the real−time response curve showed the binding of hPRR from the fat body to be three times higher than that of the mock controls at the point of maximum response. The difference detected was 84 arc seconds (Fig. 2B) . It can be calculated that 1 μg of crude protein containing hPRR increased the response by 0.56 arc seconds. However, no difference was observed between hPRR−ΔTMΔCD obtained from the hemolymph and the mock controls (Fig. 2B) . The hPRR−ΔTMΔCD was expressed partly in hemolymph (Fig. 1B) and partly in fat body. Binding affinity showed only in the microsomal fraction of fat body. The hPRR−ΔTMΔCD is composed of hydrophilic and hydrophobic parts that might be associated with membrane, which might be the reason of showing binding affinity.
To further determine the binding affinities of hPRR−ΔTMΔCD, purified hPRR and hPRR−ΔTMΔCD were diluted to the same concentration in 50 mM sodium phosphate buffer containing 150 mM NaCl and 0.2% DDM, and then analyzed using the biosensor. The binding affinity of hPRR was confirmed whilst hPRR−ΔTMΔCD was found to show no such affinity (Fig. 2C ). This suggests that full−length hPRR, but not the secreted extracellular domain, possesses the ability to bind with human renin.
Binding assays using different concentrations (0.13~1 μM) of purified hPRR and hPRR−ΔCD were also performed. The response of hPRR−bound renin showed a ΔCD was performed at various concentrations (0.13-1μM). Also, this purified one showed binding affinity (Fig. 2D) . The K D was estimated to be 330 nM.
The K D of hPRR when bound to prorenin has previously been reported as 6.6 nM when measured using an ELISA method (12). In another study, the K D values for rat PRR binding rat prorenin and renin were 8.3 nM and 20 nM, respectively (15) . The range of binding affinities obtained from rats is similar to that of humans, probably due to an amino acid sequence homology of greater than 83% between the receptors of the two species.
Binding assay for hPRR−ΔTMΔCD fused with BmMNPV gp64 protein
To further investigate whether the binding properties of hPRR were affected by the native transmembrane domain, ΔBmgp64−hPRR−ΔTMΔCD consisting of three domains; Bmgp64 N−terminal domain (1−82 amino acids), hPRR−ΔTMΔCD and a Bmgp64 C−terminal domain (321−511 amino acids) (Fig. 3A) , was constructed. Since the ΔBmgp64−hPRR−ΔTMΔCD has a heterologous transmembrane domain, it was expressed in the fat body, as confirmed by Western blotting (Fig. 3B) . The ΔBmgp64−hPRR−ΔTMΔCD in the microsomal fraction showed a binding affinity (0.51 arc seconds/μg crude protein) (Fig. 3C) but the purified one did not (Fig. 3D) . It is inferred that the heterologous transmembrane domain cannot be replaced by a native transmembrane domain from hPRR.
Binding assay for hPRR−ΔTMΔCD expressed in the fat body To make clear why the binding affinity of ΔBmgp64−hPRR−ΔTMΔCD in the microsomal fraction was lost by its purification, hPRR−ΔTMΔCD was expressed in the fat body. The microsomal and soluble fractions of the fat body were extracted from BmMNPV/hPRR−ΔTMΔCD bacmid−injected silkworm larvae as described in the Materials and Method section. The amount of hPRR−ΔTMΔCD in the microsomal fraction was smaller than that of soluble fraction (Fig. 4A) . Interestingly, however, its binding affinity was similar to that of hPRR ( Fig. 4B; see Fig. 2B ). On the other hand, the hPRR−ΔTMΔCD in the soluble fraction showed a similar binding affinity to the corresponding fraction of the mock control samples (Fig. 4B) . The specific response of hPRR−ΔTMΔCD in the microsomal fraction was 0.48 arc seconds/μg crude protein.
Unexpectedly, the purified hPPR−ΔΤΜΔCD from the microsomal fraction was not found to bind with renin (Fig. 4C) . However, when the microsomal fraction of the mock-injected fat body of silkworm larvae was mixed into the purified hPPR−ΔTMΔCD with the ratio of 1:1, the binding affinity recovered to 64% of the microsomal fraction of hPRR−ΔTMΔCD (Fig. 4D) .
The solubilized microsomal fraction of both hPRR−ΔTMΔCD and ΔBmgp64−hPRR−ΔTMΔCD expressed in the fat body showed specific affinity, but, when they were purified, they lost the binding affinity. When microsomal fraction of mock−injected fat body of silkworm larvae was added in the purified hPRR−ΔTMΔCD, its binding affinity was recovered. It is probable that an artificial transmembrane domain stabilizes the hPRR−ΔTMΔCD and native conformation may be structurally recovered. Otherwise, the microsomal fraction mixture contains some unknown factor (for example, substrate or lipid) that attaches to detergent−hPRR−micelles and either forms. Artificial transmembrane domain and an unknown factor appear to be absent following purification, thereby losing the binding affinity.
Mendrola et al. (16) reported that epidermal growth factor (ErB) receptor was stabilized by transmembrane domain interaction. Chiang and Knowles (17) reported that transmembrane domain interactions affected the stability of the extracellular domain of the human triphosphate diphosphohydrolase (NTPDase). However, Chen et al. (18) reported that when human granulocyte−macrophage colony−stimulating factor was expressed in silkworm pupae, its activity was lost due to its purification process.
In conclusion, we demonstrated that the native transmembrane domain of hPRR plays an important role in the mechanism of binding with human renin. The extracellular domain in the microsomal fraction of the fat body was observed to be bound with human renin whilst no affinity was observed after purification. This indicates that either any conformation change of hPRR due to deletion of transmembrane domain or unidentified factor in the microsomal fraction of the fat body may interact with the extracellular domain of hPRR. This clarification is highly important in elucidating the interaction of hPRR with its ligand. For the solubility test, the following non-ionic detergents were tested: DDM, n-octyl β-D-glucoside, Triton X-100, CHAPS, sodium cholate and sucrose monolaurate. These detergents were of the highest grade and purchased from Wako Pure Chem. Ind. Ltd.
(Osaka, Japan). 1.2 ml of the microsomal fraction of the fat body (to 5 mg/ml) was incubated with various detergents (0.1-3%, w/v) for 1 h at 4 °C. Samples of each homogenate (0.1 ml) were transferred to separate tubes as controls, and the remaining homogenate was centrifuged for 60 min at 114,000 x g at 4 °C. The aliquots from the homogenates, supernatants and pellets were analyzed by SDS-PAGE and Western blotting. Band intensity was quantified by Quantity ONE software (Bio-Rad, Hercules, CA, USA). 
